99 related articles for article (PubMed ID: 2663383)
1. Flat revertants of EJ human bladder carcinoma cells show two different mechanisms of reversion.
Paterson H; Mbamalu G; Marshall CJ
Ciba Found Symp; 1989; 142():134-43; discussion 143-8. PubMed ID: 2663383
[TBL] [Abstract][Full Text] [Related]
2. Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids.
Pratt CI; Wu SQ; Bhattacharya M; Kao C; Gilchrist KW; Reznikoff CA
Cancer Genet Cytogenet; 1992 Apr; 59(2):180-90. PubMed ID: 1316224
[TBL] [Abstract][Full Text] [Related]
3. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells.
Paterson H; Reeves B; Brown R; Hall A; Furth M; Bos J; Jones P; Marshall C
Cell; 1987 Dec; 51(5):803-12. PubMed ID: 3315232
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
[TBL] [Abstract][Full Text] [Related]
5. Isolation of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
Yamada H; Omata-Yamada T; Wakabayashi-Ito N; Carter SG; Lengyel P
Mol Cell Biol; 1990 Apr; 10(4):1822-7. PubMed ID: 2181289
[TBL] [Abstract][Full Text] [Related]
6. Characterization of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
Yamada H; Omata-Yamada T; Lengyel P
J Biol Chem; 1991 Feb; 266(6):4002-9. PubMed ID: 1995648
[TBL] [Abstract][Full Text] [Related]
7. Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells.
Kyprianou N; Taylor-Papadimitriou J
Oncogene; 1992 Jan; 7(1):57-63. PubMed ID: 1741165
[TBL] [Abstract][Full Text] [Related]
8. [A study on reversion of the human activated c-Ha-ras-transformed cells].
Ogiso Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
[TBL] [Abstract][Full Text] [Related]
9. [Involvement of cAMP dependent protein kinase in the reversion of a NIH/3T3 cell line transformed by a ras oncogene (EJ-NIH/3T3)].
Oda A
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):747-53. PubMed ID: 3071519
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.
Sebti SM; Tkalcevic GT; Jani JP
Cancer Commun; 1991 May; 3(5):141-7. PubMed ID: 2043425
[TBL] [Abstract][Full Text] [Related]
11. Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein.
Tilbrook PA; Paterson HF; Marshall CJ
Oncogene; 1995 Feb; 10(4):805-9. PubMed ID: 7862461
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
[TBL] [Abstract][Full Text] [Related]
13. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
Fujita H
Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
[TBL] [Abstract][Full Text] [Related]
14. A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-Ha-ras oncogene.
Fujita H; Suzuki H; Kuzumaki N; Müllauer L; Ogiso Y; Oda A; Ebisawa K; Sakurai T; Nonomura Y; Kijimoto-Ochiai S
Exp Cell Res; 1990 Jan; 186(1):115-21. PubMed ID: 2153549
[TBL] [Abstract][Full Text] [Related]
15. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
[TBL] [Abstract][Full Text] [Related]
17. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
Lebeau J; Le Chalony C; Prosperi MT; Goubin G
Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
[TBL] [Abstract][Full Text] [Related]
18. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
[TBL] [Abstract][Full Text] [Related]
19. Suppression and re-expression of transformed phenotype in hybrids of HA-ras-1-transformed rat-1 cells and early-passage rat embryonic fibroblasts.
Griegel S; Traub O; Willecke K; Schäfer R
Int J Cancer; 1986 Nov; 38(5):697-705. PubMed ID: 3533793
[TBL] [Abstract][Full Text] [Related]
20. Cellular genes possibly involved in the transformation process of the human melanoma cell line XP44 RO (Mel).
Lafarge-Frayssinet C; Daya-Grosjean L; Estrade S; Frezouls G; Sarasin A; Cassingena R
Anticancer Res; 1995; 15(4):1205-13. PubMed ID: 7654000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
